Abstract
Postpartum depression (PPD) is a significant public health concern with prevalence of major and minor depressions reaching 20 % in the first three postpartum months. Sociodemographic and psychopathology correlates of PPD are well established; however, information on the relationship between premenstrual disorders and the development of PPD is less well established. Thus, the aim of this study was to examine the role of premenstrual syndrome (PMS)/premenstrual dysphoric disorder (PMDD) as a risk factor for PPD. Premenstrual symptoms were assessed retrospectively using the premenstrual symptoms screening tool (PSST) and depression was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria and assessed using the Hamilton Depression Rating Scale (HDRS). A two-stage screening procedure was applied. In the first stage, the Patient Health Questionnaire (PHQ-9) was employed. In the second stage, women endorsing ≥5 symptoms on the PHQ-9 were administered the Structured Clinical Interview for DSM-IV, HDRS, and PSST. Hierarchical linear regression showed that history of depression and PMS/PMDD contributed an additional 2 % of the variance (p < 0.001), beyond that of sociodemographic factor effects. The full model accounted for 13 % of the variance in postpartum depressive symptoms. Using logistic regression, a significant association also emerged between PMS/PMDD and PPD (OR = 1.97). The findings of this study suggest that PMS/PMDD is an important risk factor for PPD. Women endorsing a history of PMS/PMDD should be monitored during the perinatal period.
Similar content being viewed by others
Notes
The low education variable is defined as having at most a high school diploma.
Non-Hispanic was not significantly correlated with each of the response variables thus was not included in the analyses, which may be a function of the low prevalence rate of Hispanics evidenced in the sample.
References
American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders Fourth Edition—Text Revision (DSM-IV-TR). American Psychiatric Press, Washington, DC
Angst J, Sellaro R, Merikangas KR, Endicott J (2001) The epidemiology of perimenstrualpsychological symptoms. Acta Psychiatr Scand 104:110–116
Beck CT (2001) Predictors of postpartum depression: an update. Nurs Res 50:275–285
Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR (2000) The role of gonadal steroid in postpartum depression. Amer J Psychiatr 157(6):924–930
Bloch M, Daly RC, Rubinow DR (2003) Endocrine factors in the etiology of postpartum depression. Compr Psychiatr 44:234–246
Bloch M, Rotenberg N, Koren D, Klein E (2005) Risk factors associated with the development of postpartum mood disorders. J Affect Disord 88:9–18
Bloch M, Rotenberg N, Koren D, Klein E (2006) Risk factors for early postpartum depressive symptoms. Psychiatr Prim Care 28:3–8
Borenstein JE, Dean BB, Endicott J, Wong J, Brown C, Dicerkson V (2003) Health and economic impact of the premenstrual syndrome. J Reprod Med 48:515–524
Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S (2002) Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol 100:435–444
DaCosta D, Dritsa M, Rippen N, Lowensteyn I, Khalife S (2006) Health-related quality of life in postpartum depressed women. Arch Wom Ment Health 9:95–102
Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, Yonkers KA (2012) Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 169:465–475
First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV axis I disorders, patient edition (SCID-I/P), version 2.0. New York Biometrics Research Department, New York State Psychiatric Institute
Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T (2005) Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 106:1071–1083
Halbreich U, Borenstein J, Pearlstein T, Kahn L (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 28(Suppl 3):1–23
Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296
Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL (2006) Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med 21:547–552
Johnson SR, McChesney C, Bean JA (1988) Epidemiology of premenstrual symptoms in a nonclinical sample. J Reprod Med 33:340–346
Jovanovic H, Cerin A, Karlsson P, Lundberg J, Halldin C, Nordström A (2006) PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatr Res 148:185–193
Kroenke K, Spitzer RL (2002) The PHQ-9: a new depression and diagnostic severity measure. Psych Ann 32:509–521
Lokuge S, Frey BN, Foster JA, Soares CN, Steiner M (2011) Depression in women: windows of vulnerability and new insights into the link between estrogen and serotonin. J Clin Psychiatr 72(11):1563–1569
Löwe B, Kroenke K, Herzog W, Gräfe R (2004) Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord 81:61–66
McCoy SJB, Beal M, Shipman SBM, Payton ME, Watson GH (2006) Risk factors for postpartum depression: a retrospective investigation at 4-weeks postnatal and a review of the literature. J Am Osteopath Assoc 106(4):193–198
Meaden PM, Hartlage SA, Cook-Karr J (2005) Timing and severity of symptoms associated with the menstrual cycle in a community-based sample in the Midwestern United States. Psychiatr Res 134(1):27–36
Moses-Kolko EL, Wisner KL, Price JC, Berga SL, Drevets WC, Hanusa BH et al (2008) Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil Steril 89(3):685–692
Murray L, Cooper PJ (1997) Postpartum depression and child development. Psychol Med 27:253–260
Murray L, Cooper PJ, Wilson A, Romaniuk H (2003) Controlled trial of the short-and long-term effect of psychological treatment of post-partum depression. 2. Impact on the mother child relationship and child outcome. Br J Psychiatry 182:420–427
O’Hara MW, Stuart S, Gorman LL, Wenzel A (2000) Efficacy of interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 57:1039–1045
Pearlstein T, Steiner M (2008) Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatr Neurosci 33(4):291–301
Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman E, HarrisonWM HRF, Stout AL, Yonkers KA (2000) Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatr 61:101–109
Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA (2005) Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord 85:275–282
Robertson E, Grace S, Wallington T, Stewart DE (2004) Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatr 26:289–295
Ross LE, Gilbert Evans SE, Sellers EM, Romach MK (2003) Measurement issues in postpartum depression part 1: anxiety as a feature of postpartum depression. Arch Wom Ment Health 6:51–57
Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM, Stewart DE, Meyer JH (2010) Elevated brain monoamine oxidase a binding in the early postpartum period. Arch Gen Psychiatry 67:468–474
Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338:209–216
Smith MJ, Schmidt PJ, Rubinow DR (2003) Operationalizing DSM-IV criteria for PMDD: selecting symptomatic and asymptomatic cycles for research. J Psychiatr Res 37:75–83
SPSS for Windows (2010) Rel. 19.0.0.1. Chicago: SPSS Inc
Steiner M, Macdougall M, Brown E (2003) The premenstrual symptoms screening tool (PSST) for clinicians. Arch Wom Ment Health 6:203–209
Sternfeld B, Swindle R, Chawla A, Long S, Kennedy S (2002) Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol 99:1014–1024
Weissman MM, Jensen P (2002) What research suggests for depressed women with children. J Clin Psychiatry 63:641–647
Whiffen VE, Gotlib IH (1989) Infants of postpartum depressed mothers: temperament and cognitive status. J Abn Psychol 98:274–279
Wittchen HU, Becker E, Lieb R, Krause P (2002) Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32:119–132
Acknowledgments
This work was supported by grant MH 074636 from the National Institute of Mental Health, Bethesda, MD (Drs. Stuart and Zlotnick).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buttner, M.M., Mott, S.L., Pearlstein, T. et al. Examination of premenstrual symptoms as a risk factor for depression in postpartum women. Arch Womens Ment Health 16, 219–225 (2013). https://doi.org/10.1007/s00737-012-0323-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-012-0323-x